Beijing Konruns Pharmaceutical Co., Ltd.

Chine

 
Quantité totale PI 14
Rang # Quantité totale PI 108 854
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 135 490
Symbole boursier 603590 (sse)
Capitalisation 4.368B  (CNY)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

4 0
2 0
8 0
0
 
Dernier brevet 2024 - Sulfonamide compound, pharmaceut...
Premier brevet 2006 - Haemocoagulase

Derniers inventions, produits et services

2024 Invention Sulfonamide compound, pharmaceutical composition thereof and use thereof. The present disclosure ...
2021 Invention Angiogenesis inhibitor, preparation method therefor and use thereof. The present invention falls ...
2020 Invention Anti-tumor pharmaceutical composition and method for increasing solubility of compound. A quinoli...
Invention Crystalline form of compound, method for preparing the same, pharmaceutical composition and use. ...
Invention Crystal forms of compound, preparation method therefor, pharmaceutical composition and applicatio...
2017 Invention Quinolyl-substituted carboxylic acid compound or pharmaceutically acceptable salt thereof, pharma...
Invention Quinolinyl-substituted carboxylic acid compound or pharmaceutically acceptable salt thereof, phar...
2013 Invention Agkistrodon acutus hemocoagulase-b. The present invention provides agkistrodon acutus hemocoagula...
2011 Invention Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical c...
Invention Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical c...
Invention Phosphorus-containing group-substituted quinoline, its preparation process, medical composition c...
Invention Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical...
2010 Invention Haemocoagulase. The present invention provides a venene haemocoagulase gene and its expression fo...
2009 Invention Agkistrodon acutus . Agkistrodon acutus in the present invention is a serine proteinase having a ...